NR4A1 and carcinoma: Sixty-four percent of breast carcinomas with negative oestrogen receptors (ER) and 55% of those with negative progesterone receptor (PR) status express significantly higher levels of VEGF-A than hormonal receptor positive carcinomas (P<0.001 and P=0.004, respectively).